Press Releases

DUBLIN--(BUSINESS WIRE)-- The "Investigation Report on China's Insulin Aspart Market, 2018-2022" report has been added to ResearchAndMarkets.com's offering. The rapid development of the Chinese economy in the past three decades has changed people's dietary habits and reduced physical activities

MILWAUKEE--(BUSINESS WIRE)-- Physicians Realty Trust (NYSE: DOC) (the “Company,” the “Trust,” “we,” “our” and “us”), a self-managed healthcare real estate investment trust, today announced results for the third quarter ended September 30, 2018. John T. Thomas, President and Chief Executive Officer of the Trust, commented, “Physicians Rea

DUBLIN--(BUSINESS WIRE)-- The "Global Bile Duct Cancer Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering. Global Bile Duct Cancer Market and Competitive Landscape - 2018, provides comprehensive insights into Bile Duct Cancer pipeline,

BEVERLY HILLS, Calif.--(BUSINESS WIRE)-- Friends of the Israel Defense Forces (FIDF) raised $60 million at its annual Western Region Gala on Thursday, Nov. 1, held at the landmark Beverly Hilton Hotel. The figure represents the most money raised at any single FIDF event in the organization’s history. The sold-out gala, which has become one of Los Angeles’ premier charitable events, united ove

IRVING, Texas--(BUSINESS WIRE)-- Exxon Mobil Corporation (NYSE:XOM):

DUBLIN--(BUSINESS WIRE)-- The "Investigation Report on China's Acarbose Market, 2018-2022" report has been added to ResearchAndMarkets.com's offering. As a result of improved living standards, ageing population, and increasing obesity rate, the incidence of diabetes has been climbing in

SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) plans to present at two upcoming investor events where Celgene management will provide an overview of the Company. The events will be webcast live and will be available in the Investor Relations section of the Company’s website at

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that NASDAQ has halted trading of the company’s common stock. The U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) and Drug Safety and Risk M

LONDON--(BUSINESS WIRE)-- The global tardive dyskinesia treatment market 2019-2023 is expected to post a CAGR of more than 4% during the forecast period, according to the latest market research report by

DUBLIN--(BUSINESS WIRE)-- The "Wearable Injectors Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering. The report predicts the global wearable injectors market to grow with a CAGR of 13.4% over the forecast

DUBLIN--(BUSINESS WIRE)-- The "Coir Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering. The report predicts the global coir market to grow at a stable CAGR over the forecast period of 2018-2024.

DUBLIN--(BUSINESS WIRE)-- The "Indian Air Purifier Market Analysis and Forecast 2023" report has been added to ResearchAndMarkets.com's offering. The Air Purifier Industry in India is anticipated to grow at a CAGR of 22% during the forecasted period of 2018-2023. The industry in Indi

DUBLIN--(BUSINESS WIRE)-- The "Investigation Report on China Entecavir 2018-2022" report has been added to ResearchAndMarkets.com's offering. The number of people infected with hepatitis B virus (HBV) exceeds 100 million in China, among which 20-30 million suffering from chronic Hepatiti

DUBLIN--(BUSINESS WIRE)-- The "Investigation Report on China's Omeprazole Market, 2018-2022" report has been added to ResearchAndMarkets.com's offering. The global market size of gastric ulcer drugs exceeded USD 8 billion. In 1988, Swedish company Astra (now known as AstraZeneca) developed a ne

LYON, France--(BUSINESS WIRE)-- MaaT Pharma announced today that the company will present a poster summarizing the complete results from its ODYSSEE Phase 1b/2a trial (